Cited by 62Neuroinflammation and Neurodegeneration MechanismsStroke Rehabilitation and RecoveryNeurological Disease Mechanisms and Treatments

Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions

Open access
Herz, Josephine, Reitmeir, Raluca, Hagen, Sabine I., Reinboth, Barbara S., Guo, Zeyun, Zechariah, Anil, ElAli, Ayman, Doeppner, Thorsten R. +5 more·2012·Neurobiology of Disease

Abstract

Vascular endothelial growth factor (VEGF) has potent angiogenic and neuroprotective effects in the ischemic brain. Its effect on axonal plasticity and neurological recovery in the post-acute stroke phase was unknown. Using behavioral tests combined with anterograde tract tracing studies and with immunohistochemical and molecular biological experiments, we examined effects of a delayed i.c.v. delivery of recombinant human VEGF(165), starting 3 days after stroke, on functional neurological recovery, corticorubral plasticity and inflammatory brain responses in mice submitted to 30 min of middle cerebral artery occlusion. We herein show that the slowly progressive functional improvements of motor grip strength and coordination, which are induced by VEGF, are accompanied by enhanced sprouting of contralesional corticorubral fibres that branched off the pyramidal tract in order to cross the midline and innervate the ipsilesional parvocellular red nucleus. Infiltrates of CD45+ leukocytes were noticed in the ischemic striatum of vehicle-treated mice that closely corresponded to areas exhibiting Iba-1+ activated microglia. VEGF attenuated the CD45+ leukocyte infiltrates at 14 but not 30 days post ischemia and diminished the microglial activation. Notably, the VEGF-induced anti-inflammatory effect of VEGF was associated with a downregulation of a broad set of inflammatory cytokines and chemokines in both brain hemispheres. These data suggest a link between VEGF's immunosuppressive and plasticity-promoting actions that may be important for successful brain remodeling. Accordingly, growth factors with anti-inflammatory action may be promising therapeutics in the post-acute stroke phase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2011.12.026

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Contralesional sprouting after growth factor treatment is associated with profound alterations of gene expression, including downregulation of axonal growth inhibitors and inflammatory signals near the contralesional pyramidal tract.

    “Contralesional sprouting after treatment with growth factors is associated with profound alterations of gene expression, including the downregulation of axonal growth inhibitors19,24 and inflammatory signals19,31 in the vicinity of the contralesional pyramidal tract.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Authors
Herz, J., Reitmeir, R., Hagen, S. I., Reinboth, B. S., Guo, Z., Zechariah, A., ElAli, A., Doeppner, T. R., Bacigaluppi, M., Pluchino, S., Kilic, Ü., Kilic, E., & Hermann, D. M.
Affiliations
  • Essen University Hospital (DE)
  • IRCCS Ospedale San Raffaele (IT)
Corresponding author
Hermann, Dirk M.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2012-03
Volume
45
Issue
3
Pages
1077-1085
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2113117126
Cited by
62
References
45
Citations by year
2026: 1 · 2025: 3 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 10 · 2013: 5 · 2012: 6
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • BORIS (University Library Bern) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • German Research Foundation (HE3173/2-1, HE3173/3-1)
  • Dr. Werner Jackstädt Foundation
  • Heinz Nixdorf Foundation
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
vascular endothelial growth factor, VEGF165, intracerebroventricular administration, middle cerebral artery occlusion, focal cerebral ischemia, stroke recovery, anti-inflammatory activity, microglial activation, leukocyte infiltration, inflammatory cytokines, chemokines, red nucleus, corticospinal tract, brain remodeling
MeSH terms
Animals, Anti-Inflammatory Agents, Biotin, Brain Edema, Cerebral Cortex, Cerebral Infarction, Dextrans, Disease Models, Animal, Gene Expression Regulation, Injections, Intraventricular, Functional Laterality, Male, Mice, Inbred C57BL, Motor Activity, Nerve Degeneration, Neural Pathways, Neuronal Plasticity, Organometallic Compounds, Organophosphorus Compounds, Red Nucleus, Cytokines, Hand Strength, Infarction, Middle Cerebral Artery, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review